RPS6KA1 and lung cancer: Consequently, this pathway fuels the proliferation potential of this cell line dramatically as shown in Fig. 3A. The activation of mTOR by different RSK phosphorylation levels is reflected in vivo by downregulation of RSK activity in metastasis compared to primary lesions of untreated patients with lung cancer.